Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Biotin supplementation during isotretinoin treatment for acne may help maintain skin hydration and improve hair growth.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Keratin proteins are crucial for hair structure and strength.

PRP injections improve periorbital wrinkles and show promise as a treatment.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Omeprazole effectively treats severe acid reflux in children for short-term use, but long-term safety needs more research.

No cure for female pattern hair loss, but various effective treatments exist.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Mutant mice help researchers understand hair growth and related genetic factors.

Minoxidil's effectiveness decreases as vehicle evaporates; concentration and thermodynamic activity matter.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.